NCT01225770

Brief Summary

Experimental and clinical studies in adults have reported that green tea catechins prevent influenza infection. In this clinical randomized study, the investigators aimed to determine the effects of gargling with green tea on the prophylaxis of influenza infection among high school teenagers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
640

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Nov 2010

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 21, 2010

Completed
11 days until next milestone

Study Start

First participant enrolled

November 1, 2010

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

February 15, 2013

Status Verified

February 1, 2013

Enrollment Period

3.4 years

First QC Date

October 19, 2010

Last Update Submit

February 12, 2013

Conditions

Keywords

green teagarglingprophylaxisinfluenzaRespiratory Tract Infectionshigh school students

Outcome Measures

Primary Outcomes (1)

  • the incidence rates of influenza infection

    Until 3 months gargling

Secondary Outcomes (6)

  • severity of influenza symptoms

    until 3 months gargling

  • influenza-free time during the study period

    until 3 months gargling

  • incidence of complications

    until 3 months gargling

  • incidence rates of upper respiratory tract infections

    until 3 months gargling

  • incidence of days of absence from school

    until 3 months gargling

  • +1 more secondary outcomes

Study Arms (2)

Green tea

EXPERIMENTAL

Gargling with green tea

Dietary Supplement: green tea

water

ACTIVE COMPARATOR

Gargling with water

Dietary Supplement: green tea

Interventions

green teaDIETARY_SUPPLEMENT

Gargling three times daily for 90 days

Green teawater

Eligibility Criteria

Age15 Years - 20 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • aged from 15 to 20 years
  • obtained written informed consent from both the student and parent before participation
  • possible to gargle during 90 days
  • possible to fill in questionnaire

You may not qualify if:

  • Possessing allergy to green tea
  • Possessing history of influenza infection within 6 months before entering the study
  • Possessing severe immune disease or whole body infection
  • severe cardiac, respiratory, renal, or hepatic dysfunction
  • diagnosed as inadequate to participate in the study by student doctor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Shizuoka

Shizuoka, Shizuoka, Japan

RECRUITING

Related Publications (1)

  • Ide K, Yamada H, Matsushita K, Ito M, Nojiri K, Toyoizumi K, Matsumoto K, Sameshima Y. Effects of green tea gargling on the prevention of influenza infection in high school students: a randomized controlled study. PLoS One. 2014 May 16;9(5):e96373. doi: 10.1371/journal.pone.0096373. eCollection 2014.

MeSH Terms

Conditions

Influenza, HumanRespiratory Tract Infections

Interventions

Tea

Condition Hierarchy (Ancestors)

InfectionsOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Hiroshi Yamada, MD, PhD

    University of Shizuoka

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2010

First Posted

October 21, 2010

Study Start

November 1, 2010

Primary Completion

April 1, 2014

Study Completion

August 1, 2014

Last Updated

February 15, 2013

Record last verified: 2013-02

Locations